Plant-derived natural products in clinical trials, Generic name & Number of recruiting clinical trialsb: indications (potential mechanism of action) Flashcards
β-Lapachone
1 trial: Solid tumors (E2F1 pathway activator)
Curcumin
26 trials: Cognitive impairment, different types of cancer (NF-κB inhibition)
Epigallocatechin-3-O-gallate
14 trials: Epstein-Barr virus reactivation in remission patients with nasopharyngeal carcinoma, multiple system atrophy, Alzheimer’s disease (cell growth arrest and apoptosis induction)
Genistein
5 trials: Colon cancer, rectal cancer, colorectal cancer (protein-tyrosine kinase inhibitor, antioxidant)
Gossypol
2 trials: B-cell chronic lymphocytic leukemia, refractory chronic lymphocytic leukemia (Bcl-2 inhibitor)
Picropodophyllotoxin
Picropodophyllotoxin (tubulin binding/IGF-1R Inhibitor)
Quercetin
9 trials: Chronic obstructive pulmonary disease, Fanconi anemia (NF-κB inhibition)
Resveratrol
22 trials: Pre-diabetes, vascular system injuries, lipid metabolism disorders (including non-alcoholic fatty liver disease) (NF-κB inhibition)